论文部分内容阅读
目的观察静脉滴注人免疫球蛋白(IVIG)治疗小儿重症肺炎的疗效。方法 2009年2月至2011年8月收治的小儿重症肺炎60例,随机分为治疗组30例,对照组30例,两组均给予抗感染、对症支持治疗,治疗组在上述治疗的基础上加用人免疫球蛋白,200～400mg/(kg·d),连用3d。结果两组发热、呼吸困难、肺部啰音消失时间,肺部阴影消失时间、住院时间比较差异均有统计学意义(P>0.05)。结论在常规治疗基础上加用IVIG治疗小儿重症肺炎能迅速减轻症状,缩短病程,减少住院时间,提高治愈率,降低病死率。
Objective To observe the curative effect of intravenous infusion of human immunoglobulin (IVIG) on children with severe pneumonia. Methods Sixty children with severe pneumonia admitted from February 2009 to August 2011 were randomly divided into treatment group (n = 30) and control group (n = 30). Both groups were given anti-infective and symptomatic supportive treatment. On the basis of the above treatment Add human immunoglobulin, 200 ~ 400mg / (kg · d), used in conjunction with 3d. Results There were significant differences between the two groups in fever, dyspnea, disappearance of pulmonary rales, disappearance of lung shadow and hospital stay (P> 0.05). Conclusion The addition of IVIG to severe pneumonia in infants on the basis of routine treatment can rapidly reduce the symptoms, shorten the course of disease, reduce the hospitalization time, improve the cure rate and reduce the mortality.